Rapinovet 10 mg Solution is a Health Canada–registered veterinary drug (DIN 02138255) held by Intervet Canada Corp, containing Propofol. Health Canada lists its status as Cancelled Post Market (status date 27 Jun 2012). Nexara Health has matched 470 registrations of Propofol across 34 other regulated markets.
Health Canada registration
| DIN | 02138255 |
|---|---|
| Brand name | Rapinovet |
| Active ingredient | Propofol |
| Strength | 10 mg |
| Dosage form | Solution |
| Route | Intravenous |
| Company | Intervet Canada Corp |
| Status | Cancelled Post Market — 27 Jun 2012 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Propofol registered in other markets
470 registrations of the same molecule in 34 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bahrain | Diprivan | Aspen Pharma Trading Limited, Ireland. | 1 % | Emulsion For Injection/Infusion | POM | NHRA |
| Bahrain | Diprivan | Aspen Pharma Trading Limited, Ireland. | 1 % | Emulsion For Injection/Infusion | POM | NHRA |
| Bahrain | Propofol | Amneal Eu Limited, Ireland. | 10 MG/ML | Injectable Emulsion | POM | NHRA |
| Bahrain | Propofol 1% Mct/Lct Fresenius | Fresenius Kabi Deutschland GmbH, Germany. | 1 % | Emulsion For Injection/Infusion | POM | NHRA |
| Bahrain | Propofol 1% Mct/Lct Fresenius | Fresenius Kabi Deutschland GmbH, Germany. | 1 % | Emulsion For Injection/Infusion | POM | NHRA |
| Bahrain | Propofol-Lipuro | B. Braun Melsungen AG, Germany. | 1 % W/V | Emulsion For Injection/Infusion | POM | NHRA |
| Bahrain | Propofol-Lipuro | B. Braun Melsungen AG, Germany. | 1 %W/V | Emulsion For Injection/Infusion | POM | NHRA |
| Bahrain | Recofol Edta | Labatec Pharma SA, Switzerland. | 10 MG/ML | Emulsion For Injection/Infusion | POM | NHRA |
| Bolivia | Propofol | — | 10 mg/ml | Inyectable | LINAME (formulary) | |
| Brazil | Diprivan | Aspen Pharma Indústria Farmacêutica Ltda | 20 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | Novo | CMED | |
| Brazil | Diprivan | Aspen Pharma Indústria Farmacêutica Ltda | 20 MG/ML EMU INJ IV SER PREENC VD TRANS X 50 ML | Novo | CMED | |
| Brazil | Diprivan | Aspen Pharma Indústria Farmacêutica Ltda | 10 MG/ML EMU INJ IV CT FA VD TRANS X 100 ML | Novo | CMED | |
| Brazil | Diprivan | Aspen Pharma Indústria Farmacêutica Ltda | 10 MG/ML EMU INJ IV SER PREENC VD TRANS X 50 ML | Novo | CMED | |
| Brazil | Diprivan | Aspen Pharma Indústria Farmacêutica Ltda | 10 MG/ML EMU INJ IV CT 5 AMP VD TRANS X 20 ML | Novo | CMED | |
| Brazil | Diprivan | Aspen Pharma Indústria Farmacêutica Ltda | 10 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | Novo | CMED | |
| Brazil | Hyfol | Brainfarma Indústria Química E Farmacêutica S.a | 10 MG/ML EMU INJ/DIL INFUS IV CT 5 FA VD TRANS X 20 ML | Similar | CMED | |
| Brazil | Hyfol | Brainfarma Indústria Química E Farmacêutica S.a | 10 MG/ML EMU INJ/DIL INFUS IV CT 10 FA VD TRANS X 20 ML | Similar | CMED | |
| Bulgaria | Profol | Baxter Holding B.V. | 10 mg/ml emulsion for infusion | емулсия инжекционна/инфузионна | По лекарско предписание | BDA |
| Bulgaria | Propofol - Lipuro | B.Braun Melsungen AG | 10 mg/ml emulsion for injection/infusion | емулсия инжекционна/инфузионна | По лекарско предписание | BDA |
| Bulgaria | Propofol MCT/LCT Fresenius | Fresenius Kabi d.o.o. | 10 mg/ml emulsion for injection/infusion | емулсия инжекционна/инфузионна | По лекарско предписание | BDA |
| Bulgaria | Propofol PF | Полифарма България ЕООД | 10 mg/ml emulsion for injection/infusion | емулсия инжекционна/инфузионна | По лекарско предписание | BDA |
| Bulgaria | Propofol Rompharm | S.C. Rompharm Company S.R.L., | 10 mg/ml emulsion for injection/infusion | емулсия инжекционна/инфузионна | По лекарско предписание | BDA |
| Croatia | Propofol 10 mg/ml MCT Fresenius | Fresenius Kabi d.o.o. | emulz. za inj./inf., boč. 1%, 10x50 ml (10 mg/ml) | HZZO | ||
| Croatia | Propofol 10 mg/ml MCT Fresenius | Fresenius Kabi d.o.o. | emulz. za inj./inf., amp. 1%, 5x20 ml (10 mg/ml) | HZZO | ||
| Croatia | Propofol 10 mg/ml MCT Fresenius | Fresenius Kabi d.o.o. | emulz. za inj./inf., boč. 1%, 10x100 ml (10 mg/ml) | HZZO | ||
| Croatia | Propofol 20 mg/ml MCT Fresenius | Fresenius Kabi d.o.o. | emulz. za inj./inf., boč. 2%, 10x50 ml (20 mg/ml) | HZZO | ||
| Croatia | Propofol-Lipuro 10 mg/ml | B. Braun Adria d.o.o. | emulz. za inj. ili inf., 10 mg/ml, boč., 10x50 ml | HZZO | ||
| Croatia | Propofol-Lipuro 10 mg/ml | B. Braun Adria d.o.o. | emulz. za inj. ili inf., 10 mg/ml, amp., 5x20 ml | HZZO | ||
| Croatia | Propofol-Lipuro 20 mg/ml | B. Braun Adria d.o.o. | emulz. za inj. ili inf., 20 mg/ml, boč., 10x50 ml | HZZO | ||
| Czech Republic | Anesia | Baxter Holding B.V., Utrecht | 20MG/ML | Inj/Inf Eml | B | SUKL DLP |
| Czech Republic | Anesia | Baxter Holding B.V., Utrecht | 10MG/ML | Inj/Inf Eml | B | SUKL DLP |
| Czech Republic | Propofol Mct Fresenius | — | 20MG/ML | Inj/Inf Eml Isp | R | SUKL DLP |
| Czech Republic | Propofol Mct/Lct Fresenius | — | 10MG/ML | Inj/Inf Eml | R | SUKL DLP |
| Czech Republic | Propofol Mct/Lct Fresenius | — | 20MG/ML | Inj/Inf Eml | R | SUKL DLP |
| Czech Republic | Propofol-Lipuro 0,5% (5mg/mL) | — | 5MG/ML | Inj/Inf Eml | R | SUKL DLP |
| Czech Republic | Propofol-Lipuro 1 % (10mg/mL) | — | 10MG/ML | Inj/Inf Eml | R | SUKL DLP |
| Czech Republic | Propofol-Lipuro 2% (20mg/mL) | — | 20MG/ML | Inj/Inf Eml | R | SUKL DLP |
| Denmark | Norfol | Norbrook Laboratories (Ireland) Limited | 10 mg/ml | injektionsvæske, emulsion | MRP | Laegemiddelstyrelsen |
| Denmark | Profast | Baxter Holding B.V. | 10 mg/ml | injektions-/infusionsvæske, emulsion | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Profast | Baxter Holding B.V. | 20 mg/ml | injektions-/infusionsvæske, emulsion | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Propodine | Dechra Regulatory B.V. | 10 mg/ml | injektions-/infusionsvæske, emulsion | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Propofol "2care4" | 2care4 ApS | 5 mg/ml | injektions-/infusionsvæske, emulsion | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Propofol "B. Braun" | B. Braun Melsungen | 5 mg/ml | injektions-/infusionsvæske, emulsion | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Propofol "B. Braun" | B. Braun Melsungen | 10 mg/ml | injektions-/infusionsvæske, emulsion | MRP | Laegemiddelstyrelsen |
| Denmark | Propofol "B. Braun" | B. Braun Melsungen | 20 mg/ml | injektions-/infusionsvæske, emulsion | MRP | Laegemiddelstyrelsen |
| Dominican Republic | Alclab Gabofol | Armein Pharmaceuticals Pvt. Ltd. | Registered | MISPAS | ||
| Dominican Republic | Cryopofol | Gobbi Novag S.a. | Registered | MISPAS | ||
| Dominican Republic | Diprivan | Corden Pharma S.p.a. | Registered | MISPAS | ||
| Dominican Republic | Diprivan | Corden Pharma Societa Per Azioni | Registered | MISPAS | ||
| Dominican Republic | Nirfol | Aculife Healthcare Private Limited | Registered | MISPAS | ||
| Dominican Republic | Oleo-Lax | Laboratorio Internacional Argentino S.a. | Registered | MISPAS | ||
| Dominican Republic | Pentraler Aglf | Farbe Firma Pvt. Ltd. | Registered | MISPAS | ||
| Dominican Republic | Pofol | Dongkook Pharmaceutical Co.,Ltd | Registered | MISPAS | ||
| Ecuador | PROPOFOL 200mg/20ml | Pharmaservice S.a. De C.v | PROPOFOL 200mg/20mL | Emulsion Inyectable | VIGENTE | ARCSA registro sanitario |
| Finland | Curtega | Pfizer Oy | 10 mg/ml | injektio/infuusioneste, emulsio | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Curtega | Pfizer Oy | 20 mg/ml | injektio/infuusioneste, emulsio | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Diprivan | AstraZeneca Oy | 10 mg/ml | injektioneste, emulsio | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Diprivan | AstraZeneca Oy | 20 mg/ml | injektioneste, emulsio | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Profast | Baxter Holding B.V. | 10 mg/ml | injektio/infuusioneste, emulsio | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Profast | Baxter Holding B.V. | 20 mg/ml | injektio/infuusioneste, emulsio | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Propanest Vet | Primex Pharmaceuticals Oy | 10 mg/ml | injektioneste, emulsio | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Propoclear | Fort Dodge Animal Health Holland | 10 mg/ml | injektioneste, emulsio | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Greece | HIREMON INJ.EM.IN 10MG/ML BTx1 GLASS VIAL x 100 ML | Demo Abee | reimbursed | MoH deltio timwn | ||
| Greece | HIREMON INJ.EM.IN 10MG/ML BTx1 GLASS VIAL x 50 ML | Demo Abee | reimbursed | MoH deltio timwn | ||
| Greece | HIREMON INJ.EM.IN 10MG/ML BTx5 GLASS VIAL x 20 ML | Demo Abee | reimbursed | MoH deltio timwn | ||
| Greece | HIREMON INJ.EM.IN 20MG/ML BTx1 GLASS VIAL x 50 ML | Demo Abee | reimbursed | MoH deltio timwn | ||
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx1 γυάλινo φιαλίδιο 100 ML γαλάκτωμα φιαλίδιο 100 ML γαλάκτωμα | Fresenius Kabi Hellas Ανωνυμη Εμπορικη Μονοπροσωπη Εταιρια Για Τη Διανομη, Διαθεση Και Πωληση Φαρμακευτικων Προϊοντων Δ.τ. Fresenius Kabi Hellas Μονοπροσωπη Α.ε., Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx1 γυάλινo φιαλίδιο 50 ML γαλάκτωμα φιαλίδιο 50 ML γαλάκτωμα | Fresenius Kabi Hellas Ανωνυμη Εμπορικη Μονοπροσωπη Εταιρια Για Τη Διανομη, Διαθεση Και Πωληση Φαρμακευτικων Προϊοντων Δ.τ. Fresenius Kabi Hellas Μονοπροσωπη Α.ε., Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx10 γυάλινα φιαλίδια 100 ML γαλάκτωμα φιαλίδια 100 ML γαλάκτωμα | Fresenius Kabi Hellas Ανωνυμη Εμπορικη Μονοπροσωπη Εταιρια Για Τη Διανομη, Διαθεση Και Πωληση Φαρμακευτικων Προϊοντων Δ.τ. Fresenius Kabi Hellas Μονοπροσωπη Α.ε., Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx10 γυάλινα φιαλίδια 20 ML γαλάκτωμα φιαλίδια 20 ML γαλάκτωμα | Fresenius Kabi Hellas Ανωνυμη Εμπορικη Μονοπροσωπη Εταιρια Για Τη Διανομη, Διαθεση Και Πωληση Φαρμακευτικων Προϊοντων Δ.τ. Fresenius Kabi Hellas Μονοπροσωπη Α.ε., Ελλαδα | reimbursed | MoH deltio timwn | ||
| Hong Kong | Diprivan Inj 1% | Aspen Pharmacare Asia Limited O/B Aspen Pharmacare Asia Limited | Registered | DH Drug Office | ||
| Hong Kong | Fresofol Inj 1% Mct/Lct | Fresenius Kabi Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Propofol-Lipuro Emulsion For Injection/Infusion 200mg/20ml | B. Braun Medical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Propofol-Lipuro Emulsion For Injection/Infusion 500mg/50ml | B. Braun Medical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Propofol-Lipuro Inj 1% | B. Braun Medical (Hk) Ltd | Registered | DH Drug Office | ||
| Iceland | Propofol | Vistor - óskráð | 20 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Propofol Lipuro | Vistor - óskráð | 5 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Propolipid | Fresenius Kabi AB | 10 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Propolipid | Fresenius Kabi AB | 10 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Propolipid | Fresenius Kabi AB | 10 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Ireland | Diprivan 1% w/v emulsion for injection or infusion, pre-filled syringe | Aspen Pharma Trading Limited | Emulsion for injection/infusion | Marketed | HPRA | |
| Ireland | Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule | Fresenius Kabi Deutschland GmbH | Emulsion for injection/infusion | Not marketed | HPRA | |
| Ireland | Propofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, vial | Fresenius Kabi Deutschland GmbH | Emulsion for injection/infusion | Not marketed | HPRA | |
| Ireland | Propofol 1% (10 mg/ml) emulsion for injection/infusion | Fresenius Kabi Deutschland GmbH | Emulsion for injection/infusion | Marketed | HPRA | |
| Ireland | Propofol 1% (10 mg/ml) emulsion for injection/infusion in pre-filled syringe | Fresenius Kabi Deutschland GmbH | Emulsion for injection/infusion in pre-filled syringe | Marketed | HPRA | |
| Ireland | Propofol 10 mg/ml Emulsion for injection/infusion | Baxter Holding B.V. | Emulsion for injection/infusion | Marketed | HPRA | |
| Ireland | Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, ampoule | Fresenius Kabi Deutschland GmbH | Emulsion for injection/infusion | Not marketed | HPRA | |
| Ireland | Propofol 2 % (20 mg/1 ml) Fresenius emulsion for injection or infusion, vial | Fresenius Kabi Deutschland GmbH | Emulsion for injection/infusion | Not marketed | HPRA | |
| Italy | DIPRIVAN*1 flaconcino EV 1.000 mg 50 ml | Aspen Pharma Trading Limited | PROPOFOL 1.000MG 50ML 1 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | DIPRIVAN*1 flaconcino EV 500 mg 50 ml | Aspen Pharma Trading Limited | PROPOFOL 500MG 50ML 1 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | DIPRIVAN*5 fiale EV 200 mg 20 ml | Aspen Pharma Trading Limited | PROPOFOL 200MG 20ML 5 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | PROPOFOL*10 flaconcini EV 100 ml 10 mg/ml | FRESENIUS KABI ITALIA Srl | PROPOFOL 1.000MG 100ML 10 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | PROPOFOL*10 flaconcini EV 20 ml 10 mg/ml | FRESENIUS KABI ITALIA Srl | PROPOFOL 200MG 20ML 10 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | PROPOFOL*10 flaconcini EV 50 ml 10 mg/ml | FRESENIUS KABI ITALIA Srl | PROPOFOL 500MG 50ML 10 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | PROPOFOL*10 flaconcini EV 50 ml 20 mg/ml | FRESENIUS KABI ITALIA Srl | PROPOFOL 1.000MG 50ML 10 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Italy | PROPOFOL*5 fiale IV 20 ml 10 mg/ml | FRESENIUS KABI ITALIA Srl | PROPOFOL 200MG 20ML 5 UNITA' USO PARENTERALE | Classe H | AIFA liste A/H | |
| Jordan | propofol 1% MCT /LCT Fresenius Emulsion for injection or infusion | Fresenius Kabi Austria GmbH/Austria | 10.0 MG/1 ML | Emulsion for injection/infusion | NEW APPLICATION | JFDA drug registrations |
| Lebanon | Propofol 1% Mct/Lct Fresenius | Fresenius Kabi Deutschland GmbH | Emulsion for injection or infusion | A2 | MoPH | |
| MA | Diprivan | — | 500 MG | Emulsion Injectable | P | CNOPS liste des medicaments |
| MA | Diprivan | — | 200 MG | Emulsion Injectable | P | CNOPS liste des medicaments |
| MA | Propofol Mylan 20 mg/mL | — | 20 MG | Emulsion Injectable | G | CNOPS liste des medicaments |
| MA | Recofol | — | 10 MG | Emulsion Injectable | P | CNOPS liste des medicaments |
| MA | Recofol | — | 10 MG | Emulsion Injectable | P | CNOPS liste des medicaments |
| MA | Recofol | — | 10 MG | Emulsion Injectable | P | CNOPS liste des medicaments |
| Malaysia | KWALIFOL Propofol Emulsion for Injection or Infusion USP 1 % (10 mg/ml) | Synercam (M) Sdn Bhd | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Propofol Emulsion for Injection or Infusion (1% w/v) with MCT-LCT (1% w/v)-SPIVA | Baxter Healthcare (Malaysia) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Troypofol (Propofol Emulsion for I.V. Injection or Infusion 1% w/v) | Unimed Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malta | Propofol | Hospira UK Limited | Emulsion For Infusion Or Injection | Withdrawn | Medicines Authority | |
| Malta | Propofol | Hospira UK Limited | Emulsion For Infusion Or Injection | Withdrawn | Medicines Authority | |
| Malta | Propofol | Hospira UK Limited | Emulsion For Infusion Or Injection | Withdrawn | Medicines Authority | |
| Mexico | Propofol | — | Grupo Nº 2: Anestesia | CSG Compendio (formulary) | ||
| Mexico | Propofol | — | Grupo Nº 2: Anestesia | CSG Compendio (formulary) | ||
| Mexico | Propofol | — | Grupo Nº 2: Anestesia | CSG Compendio (formulary) | ||
| Mexico | Propofol | — | Grupo Nº 2: Anestesia | CSG Compendio (formulary) | ||
| Mexico | Propofol | — | Grupo Nº 2: Anestesia | CSG Compendio (formulary) | ||
| Netherlands | Diprivan-10 emulsie voor injectie of infusie, 10 mg/ml | Aspen Pharma Trading Limited | Emulsie voor infusie, Emulsie voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Diprivan-20 emulsie voor injectie of infusie, 20 mg/ml | Aspen Pharma Trading Limited | Emulsie voor injectie, Emulsie voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Propofol 10 mg/ml MCT/LCT Fresenius, emulsie voor injectie of infusie | Fresenius Kabi Nederland B.V. | Emulsie voor injectie, Emulsie voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Propofol 10 mg/ml MCT/LCT Fresenius, emulsie voor injectie/infusie in een voorgevulde spuit | Fresenius Kabi Nederland B.V. | Emulsie voor injectie, Emulsie voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Propofol 20 mg/ml MCT/LCT Fresenius, emulsie voor injectie of infusie | Fresenius Kabi Nederland B.V. | Emulsie voor injectie | Uitsluitend recept | EU national register |
See every manufacturer of Propofol worldwide →
Regulator price references for Propofol
Published list or reimbursement prices for Propofol presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Bahrain | Sayfol | 10mg/1ml | 5 X 20ML | 4.72 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Propofol-Lipuro | 50ML | 5.12 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Recofol Edta | 10mg/1ml | 5 X 20ML | 6.10 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Diprivan | 1pct | 50ML | 7.38 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Propofol | 10mg/1ml | 10 X 20ML | 10.18 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Propofol-Lipuro | 1pct | 5 X 20ML | 10.99 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Propofol 1% Mct/Lct Fresenius | 1pct | 5 X 20ML | 11.04 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Diprivan | 1pct | 5 X 20ML | 11.81 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Propofol 1% Mct/Lct Fresenius | 1pct | 10 X 50ML | 47.95 BHD | retail (max) | NHRA | 2026-09-01 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT FA VD TRANS X 20 ML | 25.78 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Oponap® | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT FA VD TRANS X 20 ML | 36.99 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Provive | 10mg/1ml | 10 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | 103.35 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propotil | 10mg/1ml | 10 MG/ML EMU INJ IV CT 5 AMP VD TRANS X 20 ML | 114.58 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Lipuro | 10mg/1ml | 10 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | 123.41 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Diprivan | 10mg/1ml | 10 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | 124.13 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT 5 FA VD TRANS X 20 ML | 128.88 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propovan | 10mg/1ml | 10 MG/ML EMU INJ CT FA VD TRANS X 50 ML | 131.48 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | 133.53 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ CX 5 AMP VD TRANS X 20 ML | 137.55 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Profolen | 10mg/1ml | 10 MG/ML EMU INJ/INFUS IV CT 5 AMP VD TRANS X 20 ML | 137.61 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ/INFUS IV CT 5 AMP VD TRANS X 20 ML | 137.61 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propovan | 10mg/1ml | 10 MG/ML EMU INJ CX 5 AMP VD TRANS X 10 ML | 156.26 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ IV CT 5 FA VD TRANS X 20 ML | 184.08 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Oponap® | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT 5 FA VD TRANS X 20 ML | 185.00 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Provive | 10mg/1ml | 10 MG/ML EMU INJ IV CT 5 FA VD TRANS X 10 ML | 188.65 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Diprivan | 10mg/1ml | 10 MG/ML EMU INJ IV SER PREENC VD TRANS X 50 ML | 202.17 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Diprivan | 10mg/1ml | 10 MG/ML EMU INJ IV CT 5 AMP VD TRANS X 20 ML | 211.71 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Provive | 10mg/1ml | 10 MG/ML EMU INJ IV CT FA VD TRANS X 100 ML | 225.67 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Provive | 10mg/1ml | 10 MG/ML EMU INJ IV CT 5 FA VD TRANS X 20 ML | 229.32 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Spiva Mct-Lct | 10mg/1ml | 10 MG/ML EMU INJ IV CT 5 FA VD TRANS X 20 ML | 237.94 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Diprivan | 20mg/1ml | 20 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | 246.39 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Lipuro | 10mg/1ml | 10 MG/ML EMU INJ IV CT FA VD TRANS X 100 ML | 246.84 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Lipuro | 20mg/1ml | 20 MG/ML EMU INJ IV CT FA VD TRANS X 50 ML | 253.61 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT 10 FA VD TRANS X 20 ML | 257.72 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Lipuro | 10mg/1ml | 10 MG/ML EMU INJ IV CX 5 AMP VD TRANS X 20 ML | 265.96 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Diprivan | 10mg/1ml | 10 MG/ML EMU INJ IV CT FA VD TRANS X 100 ML | 268.38 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Hyfol | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT 5 FA VD TRANS X 20 ML | 280.28 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propovan | 10mg/1ml | 10 MG/ML EMU INJ CX 5 FA VD TRANS X 20 ML | 280.60 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propovan | 10mg/1ml | 10 MG/ML EMU INJ CX 10 AMP VD TRANS X 10 ML | 283.19 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ CX 10 FA VD TRANS X 20 ML | 315.57 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Oponap® | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT 10 FA VD TRANS X 20 ML | 370.02 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Diprivan | 20mg/1ml | 20 MG/ML EMU INJ IV SER PREENC VD TRANS X 50 ML | 404.38 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Spiva Mct-Lct | 10mg/1ml | 10 MG/ML EMU INJ IV CT 10 FA VD TRANS X 20 ML | 475.86 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propovan | 10mg/1ml | 10 MG/ML EMU INJ CX 10 FA VD TRANS X 20 ML | 485.54 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Hyfol | 10mg/1ml | 10 MG/ML EMU INJ/DIL INFUS IV CT 10 FA VD TRANS X 20 ML | 560.57 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ CX 10 FA VD TRANS X 50 ML | 806.83 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Lipuro | 10mg/1ml | 10 MG/ML EMU INJ IV CX 10 FA VD TRANS X 50 ML | 1,271.08 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Profolen | 10mg/1ml | 10 MG/ML EMU INJ/INFUS IV CT 50 AMP VD TRANS X 20 ML | 1,376.11 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 20mg/1ml | 20 MG/ML EMU INJ CX 10 FA VD TRANS X 50 ML | 1,601.50 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Propofol | 10mg/1ml | 10 MG/ML EMU INJ CX 10 FA VD TRANS X 100 ML | 1,744.38 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Lipuro | 20mg/1ml | 20 MG/ML EMU INJ IV CX 10 FA VD TRANS X 50 ML | 2,536.12 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Lipuro | 10mg/1ml | 10 MG/ML EMU INJ IV CX 10 FA VD TRANS X 100 ML | 2,542.10 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Greece | HIREMON INJ.EM.IN 10MG/ML BTx5 GLASS VIAL x 20 ML | 10mg/1ml | 4.00 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx5x20 ML (colourless glass vial-type II) | 10mg/1ml | 4.00 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL/LIPURO INJ.EM.IN 2%(W/V) BTx1 BOTTLE x 50 ML | 2pct+50ml | 4.31 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HIREMON INJ.EM.IN 20MG/ML BTx1 GLASS VIAL x 50 ML | 20mg/1ml | 4.31 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 2% (W/V) ΒΤ x 1 γυάλινο φιαλίδιο 50 ML γαλάκτωμα γυάλινο φιαλίδιο 50 ML γαλάκτωμα | 2pct+50ml+50ml | 4.31 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx1 γυάλινo φιαλίδιο 100 ML γαλάκτωμα φιαλίδιο 100 ML γαλάκτωμα | 100ml+100ml+1pct | 6.06 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx1x100 ML (colourless glass vial-type II) (colourless glass vial-type II) | 10mg/1ml | 6.06 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL/LIPURO INJ.EM.IN 1% W/V BOTTLEx100 ML | 100ml+1pct | 6.06 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HIREMON INJ.EM.IN 10MG/ML BTx1 GLASS VIAL x 100 ML | 10mg/1ml | 6.06 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL/BAXTER INJ.EM.IN 10MG/ML BTx1x50 ML (colourless glass vial-type II) (colourless glass vial-type II) | 10mg/1ml | 7.97 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx1 γυάλινo φιαλίδιο 50 ML γαλάκτωμα φιαλίδιο 50 ML γαλάκτωμα | 1pct+50ml+50ml | 7.97 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | HIREMON INJ.EM.IN 10MG/ML BTx1 GLASS VIAL x 50 ML | 10mg/1ml | 7.97 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx10 γυάλινα φιαλίδια 20 ML γαλάκτωμα φιαλίδια 20 ML γαλάκτωμα | 1pct+20ml+20ml | 8.00 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPOFOL MCT/LCT/FRESENIUS INJ.EM.IN 1% (W/V) BTx10 γυάλινα φιαλίδια 100 ML γαλάκτωμα φιαλίδια 100 ML γαλάκτωμα | 100ml+100ml+1pct | 60.60 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Propofol Lipuro | 5mg/1ml | lykjur | 2,162.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Propolipid | 10mg/1ml | lykjur | 3,069.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Propolipid | 10mg/1ml | hgl | 8,072.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Propofol | 20mg/1ml | hgl | 11,810.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Propolipid | 10mg/1ml | hgl | 14,038.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Italy | DIPRIVAN*1 flaconcino EV 500 mg 50 ml | 500mg+50ml | PROPOFOL 500MG 50ML 1 UNITA' USO PARENTERALE | 9.51 EUR | ex-factory (classe H) | AIFA liste A/H | 2026-09-02 |
| Italy | DIPRIVAN*5 fiale EV 200 mg 20 ml | 200mg+20ml | PROPOFOL 200MG 20ML 5 UNITA' USO PARENTERALE | 19.78 EUR | ex-factory (classe H) | AIFA liste A/H | 2026-09-02 |
| United Arab Emirates | Pofol | 10mg/1ml | 50ml Glass Vial | 38.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | DIPRIVAN 10mg/ml (1%) | 10mg/1ml | 50 ml Pre-filled Syringe | 76.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Dormifor® | 10mg/1ml | 20 ml Vial x 5 | 80.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Pofol | 10mg/1ml | 20ml Ampoule x 5 | 99.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Propofol 1% MCT/LCT Fresenius | 10000mg/1000ml | 20 ml x 5 Ampoules | 120.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | DIPRIVAN 10mg/ml(1% ) Ampoule | 10mg/1ml | 20ml Ampoule x 5 | 121.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Propofol 1% MCT/LCT Fresenius | 10000mg/1000ml | 50 ml x 10 vials | 400.50 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Rapinovet (DIN 02138255) marketed in Canada?
No. Health Canada lists DIN 02138255 as Cancelled Post Market as of 27 Jun 2012.
Who holds the Canadian licence for this product?
Intervet Canada Corp is the company of record in the Health Canada Drug Product Database.
Is Propofol registered outside Canada?
Yes — Nexara Health has matched 470 registrations in 34 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02138255, status date 2012-06-27; national medicine registries: AIFA liste A/H, ARCSA registro sanitario, BDA, CMED, CNOPS liste des medicaments, CSG Compendio (formulary), DH Drug Office, EU national register, Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NPRA, SUKL DLP; price sources: AIFA liste A/H, CMED, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02138255, status date 2012-06-27; national medicine registries: AIFA liste A/H, ARCSA registro sanitario, BDA, CMED, CNOPS liste des medicaments, CSG Compendio (formulary), DH Drug Office, EU national register, Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NPRA, SUKL DLP; price sources: AIFA liste A/H, CMED, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA.
Health Canada Drug Product Database (DPD), DIN 02138255, status date 2012-06-27; national medicine registries: AIFA liste A/H, ARCSA registro sanitario, BDA, CMED, CNOPS liste des medicaments, CSG Compendio (formulary), DH Drug Office, EU national register, Fimea Perusrekisteri, HPRA, HZZO, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NHRA, NPRA, SUKL DLP; price sources: AIFA liste A/H, CMED, EDE, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.